ImmunityBio has surged over 200% YTD, yet I see little fundamental justification for its current $10B enterprise value. Click here to read why IBRX is a Sell.
High-throughput sequencing, single-cell technologies, and large-scale population studies have transformed genetics and genomics into data-intensive ...
The longevity industry has reached an inflection point. With companies like Function Health raising hundreds of millions in ...
Microplastic (MP) pollution poses a major concern, especially in aquatic environments, necessitating efficient detection technologies to safeguard marine life as well as human health. However, ...
Microplastic (MP) pollution poses a major concern, especially in aquatic environments, necessitating efficient detection technologies to safeguard ...
Abstract: Various methods for assessing the stability of power systems and components are available, with the most prominent small-signal techniques being eigenvalue-based and impedance-based ...
DBAT (Deep learning-based Bio-sequencing Analysis Toolkit) is a versatile toolkit for biological sequencing data analysis, consisting of two deep learning modules: deepPeak: A deep learning framework ...
LAS VEGAS (KLAS) – A possible biological laboratory found at a home in Las Vegas on Saturday may be connected to a similar incident in California, where officials found infectious agents such as HIV ...
NEWARK, Del., Jan. 29, 2026 /PRNewswire/ -- Avobis Bio LLC, a clinical stage company developing implantable cell therapies, announced that expanded primary analysis results from the STOMP2 trial were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results